Equity Sector Funds Very High Risk Fund Managers: Viraj Kulkarni, Brijesh Shah, Ritika Behera, Gaurav Satra
Equity Sector Funds Very High Risk
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
Expert-managed portfolios tailored to your financial goals.
Estimation is based on the past performance
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | 1.18% | -0.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -4.69% |
| Category returns | 2.7% | 1.75% | -2.37% | -3.49% | 5.08% | 11.21% | 22.55% | 14.64% | 13.67% | 12.57% | N/A |
| Absolute returns | 1.18% | -0.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -4.69% |
| Rank within category | 16 | 15 | 18 | 18 | 17 | 15 | 11 | 11 | 10 | 5 | N/A |
| Total Schemes in Category | 18 | 18 | 17 | 17 | 16 | 14 | 10 | 10 | 9 | 4 | N/A |
| Sector Funds | 2025 | 2026 |
|---|---|---|
| Yearly returns | N/A | -2.61% |
| Q1 returns | N/A | -5.93% |
| Q2 returns | N/A | 3.53% |
| Q3 Returns | N/A | N/A |
| Q4 Returns | N/A | N/A |
Expense ratio: 2.41%
Inclusive of GST
Exit load
0.50% on or before 30D, Nil after 30D
| Alpha | -1.07021 |
| Beta | 0.3339 |
| Sharpe Ratio | -0.596567 |
| Sortino Ratio | -0.885016 |
| R-Squared | 0.1337 |
| Tracking Error | 4.3961 |
| Downside Risk | 9.3844 |
| Std. Deviation (Annualised) | 12.8288 |
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Expense Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth | 4% | 0.18% | -4.06% | -4.79% | 6.1% | 26.51% | 15.9% | 0% | 19.06% | 6,293.14 | 1.87 | 0.39 | Very High |
| UTI Healthcare Fund - Regular Plan - IDCW | 3.35% | 2.8% | -2.58% | -3.79% | 6.5% | 24.47% | 14% | 12.42% | 14.57% | 1,055.53 | 2.28 | 0.36 | Very High |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW | 3.17% | 3.44% | -1.8% | -2.57% | 4.19% | 24.41% | 15.77% | 11.95% | 16.2% | 4,063.64 | 1.93 | 0.38 | Very High |
| Mirae Asset Healthcare Fund - Regular Plan - Growth | 1.94% | 3.52% | -0.08% | -1.69% | 7.9% | 23.34% | 14.22% | 0% | 19.09% | 2,753.72 | 1.94 | 0.34 | Very High |
| Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth | 1.08% | 1.67% | -0.9% | -1.12% | 4.56% | 22.69% | 12.42% | 0% | 18.16% | 858.87 | 2.30 | 0.34 | Very High |
| Nippon India Pharma Fund - Growth | 0.91% | 0.8% | -1.76% | -4.11% | 3.57% | 21.92% | 13.45% | 14.11% | 19.63% | 7,898.24 | 1.82 | 0.33 | Very High |
| Tata India Pharma & Healthcare Fund - Regular Plan - Growth | 1.78% | -1.06% | -5.12% | -5.02% | 1.61% | 21.87% | 13.38% | 11.8% | 11.03% | 1,229.42 | 2.15 | 0.31 | Very High |
| DSP Healthcare Fund - Regular Plan - Growth | 4.24% | -1.05% | -2.98% | -5.97% | 2.45% | 21.25% | 13.37% | 0% | 19.86% | 2,891.76 | 1.94 | 0.30 | Very High |
| LIC MF Healthcare Fund - Regular Plan - Growth | 2.05% | -1.07% | -5.43% | -5.65% | 0.77% | 20.05% | 10.49% | 0% | 15.76% | 78.30 | 2.36 | 0.29 | Very High |
| Bandhan Healthcare Fund - Regular Plan - Growth Current | 1.18% | -0.1% | 0% | 0% | 0% | 0% | 0% | 0% | -4.69% | 273.07 | 2.41 | -0.60 | Very High |
| Instrument Allocation | Instrument | Assets % |
|---|---|---|
|
|
Domestic Equities | 97.45% |
| Cash & Cash Equivalents and Net Assets | 2.55% |
| Sector Allocation | Sector | Assets % |
|---|---|---|
| Pharmaceuticals & Biotechnology | 65.74% | |
| Healthcare Services | 29.26% | |
| Others | 2.55% | |
| Insurance | 2.21% | |
| IT - Services | 0.24% |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 9.65% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 8.97% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.40% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 7.14% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.12% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 6.72% |
| JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.91% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.81% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.31% |
| Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.08% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.97% |
| Triparty Repo TRP_020426_VAL | Cash & Cash Equivalents and Net Assets | 2.89% | |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.87% |
| Dr. Lal Pathlabs Ltd. | Healthcare Services | Domestic Equities | 2.79% |
| Global Health Ltd. | Healthcare Services | Domestic Equities | 2.46% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.09% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 1.92% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 1.86% |
| Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.84% |
| Krishna Institute of Medical Sciences Ltd | Healthcare Services | Domestic Equities | 1.82% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.78% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.73% |
| Shilpa Medicare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.60% |
| Aster DM Healthcare Ltd. | Healthcare Services | Domestic Equities | 1.47% |
| Star Health and Allied Insurance Company Ltd. | Insurance | Domestic Equities | 1.34% |
| Sanofi India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.18% |
| Jubilant Pharmova Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.90% |
| Medi Assist Healthcare Services Ltd. | Insurance | Domestic Equities | 0.87% |
| Healthcare Global Enterprises Ltd. | Healthcare Services | Domestic Equities | 0.84% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.75% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.66% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.59% |
| Orchid Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.42% |
| Blue Jet Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.36% |
| Inventurus Knowledge Solutions Ltd. | IT - Services | Domestic Equities | 0.24% |
| Cash Margin - CCIL | Cash & Cash Equivalents and Net Assets | 0.02% | |
| Net Current Assets | Cash & Cash Equivalents and Net Assets | -0.36% | |
| Total | 100.00% |
RETURNS
It is an Open ended scheme that primarily invests in Sector Funds.
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme benchmark is the BSE Health Care - TRI
It is classified as Very High Risk, suitable for investors with a Very High risk appetite.
Returns Delivered by the funds are as follows:
1-year: 0%
3-year: 0%
5-year: 0%
Top holdings include names such as:
The NAV is around ₹9.53 (approx.) for the Bandhan Healthcare Fund - Regular Plan - Growth.
The fund’s AUM is approximately ₹273 Cr.
The expense ratio for the Regular Plan is 2.41.
0.50% on or before 30D, Nil after 30D.
Minimum SIP starts at ₹1000.
The minimum lump sum investment is ₹1000. Often platforms may require higher in practice, but the statutory minimum remains the same.
You can start a SIP through:
Broker/agent platform like Sharescart.
Enter KYC details, choose the Regular Growth option, set SIP amount/frequency, and submit.
Yes. You can modify your SIP amount or frequency anytime online through the Sharescart platform.
You can redeem online via the Sharescart platform — choose the scheme, select the amount/units, and submit. Proceeds are credited to your bank account.
The fund managers: Viraj Kulkarni, Brijesh Shah, Ritika Behera, Gaurav Satra
This fund is suitable for investors with a Very High risk tolerance.
Get personalized Portfolio Management Services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
